Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T23:53:38.493Z Has data issue: false hasContentIssue false
  • English
  • Français

Adicción y esquizofrenia

Published online by Cambridge University Press:  12 May 2020

P. Batel
P. Batel*
Affiliation:
Unidad de Tratamiento Ambulatorio de las Enfermedades Alcohólicas, Hospital Beaujon, 100, Boulevard du Général Leclerc, 92110Clichy, Francia
Get access

Resumen

Estudios epidemiológicos en la población general y estudios basados en la evaluación clínica de poblaciones esquizofrénicas han revelado un alto grado de solapamiento entre la esquizofrenia y los trastornos adictivos. El abuso de sustancias psicoactivas (incluido el alcohol) a lo largo de la vida es tan frecuente (50%) que la posibilidad de un vínculo específico surge inevitablemente. Se han propuesto diversas hipótesis para explicar la elevada comorbilidad entre la esquizofrenia y la adicción: 1) Se ha desarrollado la hipótesis social-ambiental, pero los estudios han proporcionado datos escasos para validarla. 2) La posible vulnerabilidad biológica compartida entre la esquizofrenia y las adicciones llevó a los investigadores a explorar los determinantes genéticos comunes y a estudiar la implicación de los sistemas dopaminérgico y opioide en la etiología tanto de la esquizofrenia como del abuso y la dependencia de drogas psicoactivas. 3) Por último, la teoría de la automedicación propone que los esquizofrénicos pueden intentar contrarrestar el déficit asociado a sus trastornos’ utilizando las sustancias que toman o su conducta de tipo dependiente para afrontar sus problemas emocionales. El perfil clínico de los adictos esquizofrénicos parece mostrar algunos rasgos distintivos, como el alto nivel de comorbilidad depresiva y una dependencia muy alta de la nicotina y el alcohol, con un pronóstico muy malo. Estos pacientes son difíciles de manejar; la posibilidad de interacciones farmacológicas entre las sustancias que toman y la medicación neuroléptica requiere prudencia, y su cumplimiento también es malo. Los trastornos adictivos en esquizofrénicos son en la actualidad un tema de investigación activa del que se pretende que conduzca a identificar tratamientos específicos. La identificación temprana de trastornos adictivos en los esquizofrénicos debería hacer posible limitar su desarrollo y mejorar el pronóstico.

Keywords

alcoholismocannabiscocaínadependencia de nicotinaesquizofrenia
Type
Artículo original
Information
European Psychiatry (Ed. Española) , Volume 7 , Issue 6 , September 2000 , pp. 391 - 400
Copyright
Copyright © European Psychiatric Association 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Regier, DFarmer, MRae, DLocke, BKeith, SJudd, L, et al.Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catch-ment area (ECA) study. JAMA 1990;264:2511–8.CrossRefGoogle Scholar
Helzer, JDPryzbeck, TR.The co-occurence of alcoho-lism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988;49:219–24.CrossRefGoogle Scholar
Chong, SAChoo, HL.Smoking among Chinese patients with schizophrenia. Aust N Z J Psychiatry 1996;30:350–3.CrossRefGoogle ScholarPubMed
Dalack, GWHealy, DJMeador-Woodruff, JH.Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998;155:1490–501.CrossRefGoogle ScholarPubMed
Diwan, ACastine, MPomerleau, CSMeador-Woodruff, JHDalack, GW.Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders. Schizophr Res 1998;33:113–8.CrossRefGoogle ScholarPubMed
Forchuk, CNorman, RMalla, AVos, SMartin, ML.Smoking and schizophrenia. J Pshychiatr Ment Health Nurs 1997;4:355–9.CrossRefGoogle Scholar
Glynn, SHSussman, S.Why schizophrenic patients smoke [letter], Hosp Community Psychiatry 1990;41:1027.Google Scholar
Goff, DCHenderson, DCAmico, E.Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992;149:1189–93.Google ScholarPubMed
Jones, PBRantakallio, PHartikainen, ALIsohanni, MSipila, P.Schizophrenia as a long-term outcome of preg-nancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. Am J Psychiatry 1998;155:355–64.CrossRefGoogle Scholar
DeLeon, J.Smoking and vulnerability for schizophrenia. Schizophr Bull 1996;22:405–9.CrossRefGoogle Scholar
Leduc, PMittleman, G.Schizophrenia and psychostimu-lant abuse: a review and re-analysis of clinical eviden-ce. Psychopharmacology 1995;121:407–27.CrossRefGoogle Scholar
Kirchner, JEOwen, RRNordquist, CFischer, EP.Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatr Serv 1998;49:82–5.CrossRefGoogle ScholarPubMed
Rossenthal, RMiner, C.Differentiel diagnosis of substance-induced psychosis and schizophrenia in patient with substance use disorders. Schizophr Bull 1997;23:187–93.CrossRefGoogle Scholar
Drake, REOsher, FCNoordsy, DLHurlbut, SCTeague, GBBeaudett, MS.Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57–67.CrossRefGoogle Scholar
Zanis, DAMcLellan, ATCorse, S.Is the Addiction Severity Index a reliable and valid assessment instru-ment among clients with severe and persistent mental illness and substance abuse disorders? Community Ment Health J 1997;33:213–27.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnosis and statisti-cal manual of mental disorders. Third ed, rev. APA Press Washington: 1986.Google Scholar
Barbee, JGClark, PDCrapanzano, MSHeintz, GCKeho, CE.Alcohol and substance abuse among schizophrenic patients representing to an emergency psychiatric Service. J Nerv Ment Dis 1989;177:400–7.CrossRefGoogle Scholar
Batel, PLejoyeux, MAdès, J.Study of alcoholism among schizophrenics. In: G. D, ed. 18th Collegium Internationale Neuro-Psychopharmacologicum Congress. Nice: Raven Press; 1992, 118B.Google Scholar
Chouljian, TLShumway, MBalancio, EDwyer, EVSurber, RJacobs, M.Substance use among schizophrenic outpatients: prevalence, course, and relation to func-tional status. Ann Clin Psychiatry 1995;7:19–24.CrossRefGoogle Scholar
Clare, AW.Alcoholism and schizophrenia in Irishmen in London. A reassessment. Br J Addict 1974;69:207–12.CrossRefGoogle Scholar
Cuffel, BJ.Prevalence estimates of substance abuse in schizophrenia and their correlates. J Nerv Ment Dis 1992;180:589–92.CrossRefGoogle ScholarPubMed
Kesselman, MSSolomon, JBeaudett, MThorthon, B.Alcoholism and schizophrenia. In: Solomon, J, ed. Alcoholism and clinical psychiatry. New York: Plenum Press; 1982, 69–80.CrossRefGoogle Scholar
Soyka, M.Addiction and Schizophrenia. 1. Alcoholism and schizophrenia. Fortschr Neurol Psychiat 1994;62:71–87.CrossRefGoogle Scholar
Adler, LEOlincy, AWaldo, MHarris, JGGriffith, JStevens, K, et al.Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 1998;24:189–202.CrossRefGoogle ScholarPubMed
Glassman, AH.Cigarette smoking: implications for psychiatric illness. AmJ Psychiatry 1993;150:546–53.Google ScholarPubMed
Lohr, JBFlynn, K.Smoking and schizophrenia. Schizophr Res 1992;8:93–102.CrossRefGoogle Scholar
Brunette, MFDrake, RE.Gender differences in patients with schizophrenia and substance abuse. Contpr Psychiatry 1997;38:109–16.Google ScholarPubMed
Arndt, STyrrel, GFlaum, MAndreasen, N.Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 1992;22:379–88.CrossRefGoogle ScholarPubMed
Brady, KAnton, RBallenger, JLydiard, RAdinoff, BSelanger, J.Cocaine abuse among schizophrenic patients. AmJ Psychiatry 1990;147:1164–7.Google ScholarPubMed
Lysaker, PBell, MBeam-Goulet, JMilstein, R.Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment Dis 1994;182:109–12.CrossRefGoogle Scholar
Mueser, KTVarnold, PRLevinson, DFSingh, HBellack, ASKee, K, et al.Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990;16:31–56.CrossRefGoogle ScholarPubMed
Shaner, AKhalsa, MRoberts, LWilkins, JAnglin, DHsieh, S.Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 1993;150:768–62.Google ScholarPubMed
Stone, AGreenstein, RGamble, GMcLellan, A.Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication. Hosp Community Psychiatry 1993;44:176–7.Google ScholarPubMed
Yesavage, JZarcone, V.History of drug abuse and dan-gerous behavior in inpatient schizophrenics. J Clin Psychiatry 1983;44:259–61.Google ScholarPubMed
Goldstein, MDeutch, AY.Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J 1992;6:2413–21.CrossRefGoogle ScholarPubMed
Wolf, SSHyde, TMWeinberger, DR.Neurobiology of schizophrenia. Curr Opin Neurol Neurosurg 1993;6:86–92.Google ScholarPubMed
Volavka, JDavis, LGEhrlich, HY.Endorphins, dopami-ne, and schizophrenia. Schizophr Bull 1979;5:227–39.CrossRefGoogle Scholar
Schmauss, CEmrich, HM.Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia. Biol Psychiatry 1985;20:1211–31.CrossRefGoogle ScholarPubMed
Heinz, ASchmidt, LGReischies, FM.Anhedonia in schizophrenic, depressed, or alcohol-dependent patients: Neurobiological correlates. Pharmacopsychiatry 1994;27(Suppl 1):7–10.CrossRefGoogle ScholarPubMed
Rimmer, JJacobsen, B.Alcoholism in schizophrenics and their relatives. J Stud Alcohol 1977;38:1781–4.CrossRefGoogle ScholarPubMed
Kendler, KSTsuang, MT.Outcome and familial psycho-pathology in schizophrenia. Arch Gen Psychiatry 1988;45:338–16.CrossRefGoogle Scholar
Noordsy, DLDrake, REBiesanz, JCMcHugo, GJ.Family history of alcoholism in schizophrenia. J Nerv Ment Dis 1994;182:651–5.CrossRefGoogle Scholar
Gejman, PVRam, AGelenter, JFriedman, ECao, QPickar, D, et al.No structural mutation in the dopamine D2 receptor (DRD2) gene in alcoholism or schizophrenia. Analysis using denaturing gradiant gel electropho-resis. JAMA 1994;271:204–8.CrossRefGoogle ScholarPubMed
Krebs, MOSautel, FBourdel, MCSokoloff, PSchwartz, JCOlie, JP, et al.Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry 1998;3:337–41.CrossRefGoogle Scholar
Krausz, MMass, RHaasen, CGross, J.Psychopathology in patients with schizophrenia and substance abuse: a comparative clinical study. Psychopathology 1996;29:95–103.CrossRefGoogle ScholarPubMed
Jeste, DVGladsjo, JALindamer, LALacro, JP.Medical comorbidity in schizophrenia. Schizophr Bull 1996;22:413–30.CrossRefGoogle Scholar
Owen, RRFischer, EPBooth, BMCuffel, BJ.Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996;47:853–8.Google ScholarPubMed
Wilkins, JN.Pharmacotherapy of schizophrenia patients with comorbid substance abuse. Schizophr Bull 1997;23:215–28.CrossRefGoogle ScholarPubMed
Addington, JDuchak, V.Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997;96:329–33.CrossRefGoogle Scholar
Dixon, LHass, GHWeiden, PJSweeney, JFrances, AJ.Drug abuse in schizophrenic patients: clinical correlates and reasons for use. AmJ Psychiatry 1991;148:224–30.Google ScholarPubMed
Pristach, CASmith, CM.Self-reported effects of alcohol use on symptoms of schizophrenia. Psychiatr Serv 1996;47:421–3.Google ScholarPubMed
Noordsy, DLDrake, RETeague, GBOsher, FCHurlbut, SCBeaudett, MS, et al.Subjective experiences related to alcohol use among schizophrenics. J Nerv Ment Dis 1991;179:410–4.CrossRefGoogle ScholarPubMed
Newhouse, PAHughes, JR.The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br J Addict 1991;86:521–6.CrossRefGoogle ScholarPubMed
Alpert, MSilvers, KN.Perceptual characteristics distin-guishing auditory hallucinations in schizophrenia and acute alcoholic psychoses. Am J Psychiatry 1970;127:298–302.CrossRefGoogle ScholarPubMed
Negrete, JKnapp, WDouglas, DSmith, W.Cannabis affeets the severity of schizophrenic symptoms: results of a clinical survey. Psyhol Med 1986;16:515–20.CrossRefGoogle ScholarPubMed
Knudsen, PVilmar, T.Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr Scand 1984;69:162–74.CrossRefGoogle Scholar
Lysaker, PHBell, MDBioty, SMZito, WS.Cognitive impairment and substance abuse history as predictors of the temporal stability of negative symptoms in schizophrenia. J Nerv Ment Dis 1997;185:21–6.CrossRefGoogle Scholar
Serper, MAlpert, MRichardson, NDickson, SAlien, MWerner, A.Clinical effects of recent cocaine use on patients with acute schizophrenia. AmJ Psychiatry 1995;152:1464–9.Google ScholarPubMed
Baigent, MHolme, GHafner, J.Self reports of the inte-raction between substance abuse and schizophrenia. Aust N Z J Psychiatry 1995;29:69–74.CrossRefGoogle Scholar
Mueser, KTNishith, PTracy, JIDegirolamo, JMolinaro, M.Expectations and motives for substance use in schi-zophrenai. Schizophr Bull 1995;21:367–78.CrossRefGoogle Scholar
Smith, GL.Schizophrenia, smoking, and boredom [let-ter], Am J Psychiatry 1996;153:583–4.Google Scholar
Brunette, MFMueser, KTXie, HDrake, RE.Relationships between symptoms of schizophrenia and substance abuse. J Nerv Ment Dis 1997;185:13–20.CrossRefGoogle ScholarPubMed
Buckley, PF.Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat 1998;15:113–6.CrossRefGoogle Scholar
Pristach, CSmith, C.Medication compliance and substance abuse among schizophrenic patients. Hosp Community Psychiatry 1990;41:1345–8.Google ScholarPubMed
Salokangas, RKSaarijarvi, STaiminen, TLehto, HNiemi, HAhola, V.et al.Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 1997;23:55–60.CrossRefGoogle Scholar
Bailey, LGMaxwell, SBrandabur, MM.Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1, 027 patients. Psychopharmacol Bull 1997;33:177–81.Google ScholarPubMed
Buckley, PF.New antipsychotic agents: emerging clinical profiles. J Clin Psychiatry 1999;60(Suppl 1): 12–7; dis-cussion 28-30.Google ScholarPubMed
Casey, DE.Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia. J Clin Psychiatry 1998;59(Suppl 3):31–7.Google ScholarPubMed
Conley, RRKelly, DLGale, EA.Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse. Schizophr Res 1998;33:95–101.CrossRefGoogle ScholarPubMed
Dixon, LWeiden, PJHaas, GSweeney, JFrances, AJ.Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr Psychiatry 1992;33:121–2.CrossRefGoogle ScholarPubMed
Duke, PJPantelis, CBarnes, TRE.South Westminster schizophrenia survey-Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 1994;164:630–6.CrossRefGoogle ScholarPubMed
Olivera, AKiefer, MManley, N.Tardive dyskinesia in psychiatric patients with substance abuse disorders. Am J Drug Alcohol Abuse 1990;16:57–66.Google Scholar
Blanchard, JJSquires, DHenry, THoran, WPBogenschutz, MLauriello, J, et al.Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping. J Nerv Ment Dis 1999;187:72–9.CrossRefGoogle ScholarPubMed
Addington, JAddington, D.Effect of substance misuse in early psychosis. Br J Psychiatry 1998;172(Suppl):134–6.CrossRefGoogle ScholarPubMed
Hambrecht, MHafner, H.Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996;40:1155–63.CrossRefGoogle ScholarPubMed
Hambrecht, MHafner, H.Sensitivity and specificity of relatives’ reports on the early course of schizophrenia. Psychopathology 1997;30:12–9.CrossRefGoogle ScholarPubMed
Kasch, KLKlein, DN.The relationship between age at onset and comorbidity in psychiatric disorders. J Nerv Ment Dis 1996;184:703–7.CrossRefGoogle ScholarPubMed
Mason, PHarrison, GGlazebrook, CMedley, ICroudace, T.The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization. Br J Psychiatry 1996;169:580–6.CrossRefGoogle Scholar
Mueser, KTDrake, REAckerson, THAlternan, AIMiles, KMNoordsy, DL.Antisocial personality disorder, con-duct disorder, and substance abuse in schizophrenia. J Abnorm Psychol 1997;106:473–7.CrossRefGoogle Scholar
North, CSPollio, DESmith, EMSpitznagel, EL.Correlates of early onset and chronicity of homelessness in a large urban homeless population. J Nerv Ment Dis 1998;186:393–400.CrossRefGoogle Scholar
Rabinowitz, JBromet, EJLavelle, JCarlson, GKovasznay, BSchwartz, JE.Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol Med 1998;28:1411–9.CrossRefGoogle ScholarPubMed
Sevy, SKay, SOpler, LPraag, H.Significance of cocaine history in schizophrenia. J Nerv Ment Dis 1990;178:642–8.CrossRefGoogle Scholar
Seibyl, JSatel, SAnthony, DSouthwick, SKrystal, JCharney, D.Effects of cocaine on hospital course in schizophrenia. J Nerv Ment Dis 1993;181:31–7.CrossRefGoogle Scholar
Swofford, CDKasckow, JWScheller-Gilkey, GInderbitzin, LB.Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996;20:145–51.CrossRefGoogle Scholar
Alternan, AIErdlen, FRMcLellan, AT.Problem drinking in hospitalized schizophrenic patients. Addict Behav 1980;5:273–6.CrossRefGoogle Scholar
Brady, KTKilleen, TJarrell, P.Depression in alcoholic schizophrenic patients. AmJ Psychiatry 1993;150:1255–6.Google ScholarPubMed
Batel, PLejoyeux, MAdès, J.Prevalence and severity of alcoholism among schizophrenics: a clinical study. In: 4th ESBRA Congress; 1993. Santa Margherita Ligure (Genova), Italy: Pergamon Press, 1993, 242.Google Scholar
Soyka, MAlbus, MKathmann, NFinelli, AHofstetter, SHolzbach, R, et al.Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatry Clin Neurosci 1993;242:362–72.CrossRefGoogle ScholarPubMed
Kozaric-Kozaric, DFolnegovic-Smalc, VFolnegovic, ZMaruic, A.Influence of alcoholism on the pronosis of schizophrenic patients. J Stud Alcohol 1995;56:622–7.CrossRefGoogle Scholar
Osher, FDracke, RNoordsy, DTeague, G.Correlates and outcomes of alcohol use disorder among rural out-patients with schizophrenia. J Clin Psychiatry 1994;55:109–13.Google ScholarPubMed
Heila, HIsometsa, ETHenriksson, MMHeikkinen, MEMarttunen, MJLonnqvist, JK.Suicide and schizophrenia: a nationwide psychological autopsy study on age-and sex-specific clinical characteristics of 92 suicide victims with schizophrenia [comments]. Arn J Psychiatry 1997;154:1235–42.Google Scholar
VanAmmers, ECSellman, JDMulder, RT.Temperament and substance abuse in schizophrenia: is there a relationship? J Nerv Ment Dis 1997;185:283–8.CrossRefGoogle Scholar
Fowler, ILCarr, VJCarter, NTLewin, TJ.Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998;24:443–55.CrossRefGoogle Scholar
Blum, A.The possible role of tobaceo cigarette smoking in hyponatremia in schizophrenic inpatients. JAMA 1984;252:2864–5.CrossRefGoogle Scholar
Dalack, GWMeador-Woodruff, JH.Smoking, smoking with-drawal and schizophrenia: case reports and a review of the literature. Schizophr Res 1996;22:133–41.CrossRefGoogle Scholar
Gopalaswany, AKMorgan, R.Smoking in chronic schizophrenic. Br J Psychiatry 1986;149:523.CrossRefGoogle Scholar
Masterson, EO’Shea, B.Smoking and malignaney in schizophrenia. Br J Psychiatry 1984;145:429–32.CrossRefGoogle Scholar
Witteman, JCMGrobbee, DEValkenburg, HAVanhemenrt, AMStijnen, THofman, A.Cigarette smoking and the development and progression of aortic atherosclerosis-A 9-year population-based follow-up study in women. Circulation 1993;88:2156–62.CrossRefGoogle ScholarPubMed
Hamera, ESchneider, JKDeviney, S.Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 1995;183:559–65.CrossRefGoogle Scholar
Tsuang, JWHo, APEckman, TAShaner, A.Dual diagnosis treatment for patients with schizophrenia who are substance dependent. Psychiatr Serv 1997;48:887–9.Google ScholarPubMed
American Pyschiatric Association Guideline for the treatment of patients with substance use disorders. Alcohol, cocaine, opioids. Am J Psychiatry 1995;152(Suppl):1–59.CrossRefGoogle Scholar
Miner, CRRosenthal, RNHellerstein, DJMuenz, LR.Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders [comments], Arch Gen Psychiatry 1997;54:706–12.CrossRefGoogle Scholar
Haywood, TKravitz, HGrossman, LCavanaugh, JJDavis, JLewis, D.Predicting the ‘revolving door’ pheno-menon among patients with schizophrenic, schizoaffec-tive, and affective disorders [comments]. AmJ Psychiatry 1995;152:856–61.Google Scholar
Hansell, S.Treatment of comorbid schizophrenia and substance abuse disorders. New Dir Ment Health Serv 1997;73:65–73.CrossRefGoogle Scholar
Fenton, WSBlyler, CRHeinssen, RK.Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637–51.CrossRefGoogle ScholarPubMed
Gupta, SHendricks, SKenkel, AMBhatia, SCHaffke, EA.Relapse in schizophrenia: is there a relationship to subs-tance abuse? Schizoph Res 1996;20:153–6.CrossRefGoogle Scholar
Me Phillips, MAKelly, FJBames, TRDuke, PJGene-Cos, NClark, K.Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine. Schizophr Res 1997;25:141–8.CrossRefGoogle Scholar
Ziedonis, DMGeorge, TP.Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 1997;23:247–54.CrossRefGoogle ScholarPubMed
Galanter, MEgelko, SEdwards, HKatz, S.Can cocaine addiets with severe mental illness be treated along with singly diagnosed addiets? Am J Drug Alcohol Abuse 1996;22:497–507.CrossRefGoogle Scholar
Kovasznay, BFleischer, JTanenberg-Karant, MJandorf, LMiller, ADBromet, E.Substance use disor-der and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 1997;23:195–201.CrossRefGoogle Scholar
Voruganti, LNHeslegrave, RJAwad, AG.Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. J Nerv Ment Dis 1997;185:463–5.CrossRefGoogle ScholarPubMed
Buckley, PF.Substance abuse in schizophrenia: a review. J Clin Psychiatry 1998;59(Suppl 3):26–30.Google ScholarPubMed
Glazer, WM.Olanzapine and the new generation of antipsychotic agents: patterns of use. J Clin Psychiatry 1997;58(Suppl 10):18–21.Google ScholarPubMed
Walters, VLTognolini, RZRueda, FIMRueda, RMTorres, RG.New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up. Schizophr Res 1997;28:231–46.CrossRefGoogle Scholar
Freedman. Linkage of a neurophysiological deficit in schizophrenia to a chromosone 15 locus. Proc Nati Acad Sci USA 1997;945:587–92.Google Scholar